HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ricardo Blanco Selected Research

Systemic Scleroderma (Systemic Sclerosis)

8/2023E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases.
3/2022Efficacy and safety of biological drugs in interstitial lung disease associated with connective tissue diseases.
7/2021Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients.
6/2012Evaluation of a shared autoimmune disease-associated polymorphism of TRAF6 in systemic sclerosis and giant cell arteritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ricardo Blanco Research Topics

Disease

47Rheumatoid Arthritis
03/2024 - 10/2007
34Inflammation (Inflammations)
01/2023 - 10/2007
28Uveitis
01/2023 - 08/2012
27Ankylosing Spondylitis
01/2023 - 11/2012
26Vasculitis (Vasculitides)
01/2024 - 01/2011
25Giant Cell Arteritis (Horton Disease)
01/2023 - 08/2004
14Atherosclerosis
10/2022 - 01/2012
14Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2022 - 05/2013
13Interstitial Lung Diseases (Interstitial Lung Disease)
09/2023 - 01/2018
12Infections
04/2024 - 06/2014
12Psoriatic Arthritis
03/2024 - 11/2014
10Hidradenitis Suppurativa
04/2023 - 05/2009
10Insulin Resistance
06/2021 - 11/2012
10Cardiovascular Diseases (Cardiovascular Disease)
05/2019 - 12/2011
9Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis)
01/2024 - 08/2004
9Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 11/2014
9Axial Spondyloarthritis
01/2023 - 01/2018
8Autoimmune Diseases (Autoimmune Disease)
08/2023 - 06/2012
6Neoplasms (Cancer)
12/2023 - 08/2012
6Behcet Syndrome (Behcet's Syndrome)
01/2023 - 04/2015
6Macular Edema
01/2023 - 01/2013
6Anemia
04/2022 - 05/2011
6Purpura
03/2018 - 05/2014
5Herpes Zoster
03/2024 - 10/2017
5Sarcoidosis (Schaumann Disease)
01/2023 - 10/2006
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023 - 06/2012
5Anterior Uveitis
01/2022 - 01/2013
5Necrosis
01/2019 - 02/2013
4Systemic Scleroderma (Systemic Sclerosis)
08/2023 - 06/2012
4Idiopathic Pulmonary Fibrosis
01/2023 - 12/2020
4Non-Radiographic Axial Spondyloarthritis
01/2023 - 01/2021
4IgA Vasculitis (Purpura, Schoenlein Henoch)
01/2018 - 01/2015
4Pain (Aches)
01/2017 - 01/2012
3Sacroiliitis
01/2023 - 01/2021
3Aortitis
01/2023 - 05/2014
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2023 - 01/2016
3Obesity
05/2022 - 08/2020
3Scleritis (Episcleritis)
01/2022 - 05/2016
3Candidiasis (Moniliasis)
06/2021 - 12/2017
3Takayasu Arteritis (Arteritis, Takayasu's)
01/2021 - 08/2015
3Dyslipidemias (Dyslipidemia)
08/2020 - 08/2012
3Juvenile Arthritis (Juvenile Idiopathic Arthritis)
07/2018 - 01/2013
3Melanoma (Melanoma, Malignant)
03/2018 - 08/2012
3Fever (Fevers)
05/2016 - 06/2014
3Leukocytosis (Pleocytosis)
11/2014 - 01/2014

Drug/Important Bio-Agent (IBA)

29Biomarkers (Surrogate Marker)IBA
03/2024 - 01/2012
27tocilizumab (atlizumab)FDA Link
01/2023 - 03/2011
19Adalimumab (Humira)FDA Link
03/2024 - 05/2009
15Infliximab (Remicade)FDA Link
01/2023 - 05/2009
13secukinumabIBA
01/2023 - 01/2017
13C-Reactive ProteinIBA
01/2022 - 06/2014
13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2019 - 05/2009
12Adrenal Cortex Hormones (Corticosteroids)IBA
01/2021 - 07/2009
11Immunoglobulin A (IgA)IBA
08/2023 - 03/2014
10AdipokinesIBA
05/2022 - 11/2013
9Monoclonal AntibodiesIBA
01/2023 - 11/2012
9OsteoprotegerinIBA
10/2022 - 01/2014
8Janus Kinase InhibitorsIBA
12/2023 - 02/2013
8Methotrexate (Mexate)FDA LinkGeneric
01/2022 - 03/2011
7upadacitinibIBA
03/2024 - 10/2020
7CytokinesIBA
01/2023 - 04/2015
6GlucocorticoidsIBA
04/2024 - 01/2018
6Interleukin-6 (Interleukin 6)IBA
01/2023 - 12/2011
6Antirheumatic Agents (DMARD)IBA
06/2022 - 01/2017
6Prednisone (Sone)FDA LinkGeneric
01/2022 - 08/2012
5Abatacept (Orencia)FDA Link
09/2023 - 01/2018
5Proteins (Proteins, Gene)FDA Link
04/2023 - 10/2007
5Etanercept (Enbrel)FDA Link
01/2023 - 10/2006
5Immunosuppressive Agents (Immunosuppressants)IBA
12/2022 - 12/2014
5N,N-dimethylarginine (asymmetric dimethylarginine)IBA
10/2022 - 09/2013
5AdiponectinIBA
05/2022 - 05/2013
5tofacitinibIBA
01/2022 - 02/2013
5HLA-DRB1 Chains (HLA DRB1)IBA
10/2020 - 08/2004
4Immunomodulating AgentsIBA
12/2023 - 01/2016
4Janus KinasesIBA
12/2023 - 10/2020
4HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2023 - 11/2014
4Tumor Necrosis Factor InhibitorsIBA
01/2023 - 01/2012
4Certolizumab PegolFDA Link
12/2022 - 01/2016
4InterleukinsIBA
06/2021 - 01/2011
4LeptinIBA
11/2020 - 07/2013
4golimumabFDA Link
07/2018 - 01/2014
3risankizumabIBA
03/2024 - 01/2022
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2024 - 01/2018
3Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
11/2023 - 08/2015
3AntibodiesIBA
09/2023 - 01/2013
3Interleukin-17 (Interleukin 17)IBA
01/2023 - 06/2020
3Angiopoietin-2IBA
10/2022 - 07/2013
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2022 - 01/2017
3MethylprednisoloneFDA LinkGeneric
01/2022 - 01/2016
3baricitinibIBA
01/2022 - 01/2017
3ApelinIBA
06/2021 - 07/2013
3HLA-B Antigens (HLA-B)IBA
03/2021 - 04/2015
3Interleukin-33IBA
01/2021 - 01/2014
3HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 04/2015
3LipidsIBA
08/2020 - 01/2018
3Messenger RNA (mRNA)IBA
01/2020 - 04/2015
3Azathioprine (Imuran)FDA LinkGeneric
01/2019 - 07/2015
3Antinuclear AntibodiesIBA
01/2017 - 01/2014

Therapy/Procedure

58Therapeutics
03/2024 - 10/2006
12Biological Therapy
01/2023 - 02/2014